CRANE NXT CO (CXT) Fundamental Analysis & Valuation

NYSE:CXTUS2244411052

Current stock price

44.36 USD
+0.74 (+1.7%)
Last:

This CXT fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

8

1. CXT Profitability Analysis

1.1 Basic Checks

  • In the past year CXT was profitable.
  • In the past year CXT had a positive cash flow from operations.
  • CXT had positive earnings in each of the past 5 years.
  • Each year in the past 5 years CXT had a positive operating cash flow.
CXT Yearly Net Income VS EBIT VS OCF VS FCFCXT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 2025 100M 200M 300M

1.2 Ratios

  • CXT has a better Return On Assets (4.66%) than 69.35% of its industry peers.
  • With a decent Return On Equity value of 11.58%, CXT is doing good in the industry, outperforming 75.00% of the companies in the same industry.
  • With a decent Return On Invested Capital value of 7.93%, CXT is doing good in the industry, outperforming 75.81% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for CXT is above the industry average of 8.09%.
Industry RankSector Rank
ROA 4.66%
ROE 11.58%
ROIC 7.93%
ROA(3y)7.07%
ROA(5y)6.96%
ROE(3y)16.13%
ROE(5y)16.85%
ROIC(3y)11.93%
ROIC(5y)11.12%
CXT Yearly ROA, ROE, ROICCXT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 2025 5 10 15 20 25

1.3 Margins

  • CXT has a better Profit Margin (8.76%) than 79.03% of its industry peers.
  • In the last couple of years the Profit Margin of CXT has grown nicely.
  • CXT has a better Operating Margin (15.91%) than 90.32% of its industry peers.
  • In the last couple of years the Operating Margin of CXT has grown nicely.
  • Looking at the Gross Margin, with a value of 42.48%, CXT is in the better half of the industry, outperforming 71.77% of the companies in the same industry.
  • In the last couple of years the Gross Margin of CXT has grown nicely.
Industry RankSector Rank
OM 15.91%
PM (TTM) 8.76%
GM 42.48%
OM growth 3Y-6.41%
OM growth 5Y12.78%
PM growth 3Y-16.95%
PM growth 5Y5.97%
GM growth 3Y-3.13%
GM growth 5Y3.98%
CXT Yearly Profit, Operating, Gross MarginsCXT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 2025 10 20 30 40

3

2. CXT Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), CXT is creating some value.
  • CXT has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, CXT has less shares outstanding
  • The debt/assets ratio for CXT is higher compared to a year ago.
CXT Yearly Shares OutstandingCXT Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M
CXT Yearly Total Debt VS Total AssetsCXT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

2.2 Solvency

  • CXT has an Altman-Z score of 1.90. This is not the best score and indicates that CXT is in the grey zone with still only limited risk for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 1.90, CXT is doing worse than 64.52% of the companies in the same industry.
  • CXT has a debt to FCF ratio of 5.75. This is a neutral value as CXT would need 5.75 years to pay back of all of its debts.
  • With a Debt to FCF ratio value of 5.75, CXT perfoms like the industry average, outperforming 59.68% of the companies in the same industry.
  • A Debt/Equity ratio of 0.91 indicates that CXT is somewhat dependend on debt financing.
  • With a Debt to Equity ratio value of 0.91, CXT is not doing good in the industry: 84.68% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.91
Debt/FCF 5.75
Altman-Z 1.9
ROIC/WACC0.8
WACC9.88%
CXT Yearly LT Debt VS Equity VS FCFCXT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

2.3 Liquidity

  • A Current Ratio of 1.50 indicates that CXT should not have too much problems paying its short term obligations.
  • CXT has a Current ratio of 1.50. This is in the lower half of the industry: CXT underperforms 77.42% of its industry peers.
  • CXT has a Quick Ratio of 1.20. This is a normal value and indicates that CXT is financially healthy and should not expect problems in meeting its short term obligations.
  • CXT's Quick ratio of 1.20 is on the low side compared to the rest of the industry. CXT is outperformed by 68.55% of its industry peers.
Industry RankSector Rank
Current Ratio 1.5
Quick Ratio 1.2
CXT Yearly Current Assets VS Current LiabilitesCXT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

4

3. CXT Growth Analysis

3.1 Past

  • CXT shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -4.92%.
  • CXT shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 1.12% yearly.
  • The Revenue has grown by 11.43% in the past year. This is quite good.
  • CXT shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -9.71% yearly.
EPS 1Y (TTM)-4.92%
EPS 3Y-19.21%
EPS 5Y1.12%
EPS Q2Q%5.83%
Revenue 1Y (TTM)11.43%
Revenue growth 3Y7.33%
Revenue growth 5Y-9.71%
Sales Q2Q%19.49%

3.2 Future

  • Based on estimates for the next years, CXT will show a small growth in Earnings Per Share. The EPS will grow by 6.31% on average per year.
  • CXT is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.31% yearly.
EPS Next Y6.26%
EPS Next 2Y8.36%
EPS Next 3Y6.31%
EPS Next 5YN/A
Revenue Next Year6.38%
Revenue Next 2Y5.29%
Revenue Next 3Y4.31%
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CXT Yearly Revenue VS EstimatesCXT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1B 2B 3B
CXT Yearly EPS VS EstimatesCXT Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2 4 6

8

4. CXT Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 10.93, the valuation of CXT can be described as reasonable.
  • Based on the Price/Earnings ratio, CXT is valued cheaply inside the industry as 94.35% of the companies are valued more expensively.
  • CXT's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 26.54.
  • A Price/Forward Earnings ratio of 10.28 indicates a reasonable valuation of CXT.
  • 91.13% of the companies in the same industry are more expensive than CXT, based on the Price/Forward Earnings ratio.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 21.68, CXT is valued rather cheaply.
Industry RankSector Rank
PE 10.93
Fwd PE 10.28
CXT Price Earnings VS Forward Price EarningsCXT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, CXT is valued cheaper than 89.52% of the companies in the same industry.
  • CXT's Price/Free Cash Flow ratio is rather cheap when compared to the industry. CXT is cheaper than 90.32% of the companies in the same industry.
Industry RankSector Rank
P/FCF 12.87
EV/EBITDA 8.86
CXT Per share dataCXT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • CXT has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)1.74
PEG (5Y)9.75
EPS Next 2Y8.36%
EPS Next 3Y6.31%

5

5. CXT Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 1.59%, CXT has a reasonable but not impressive dividend return.
  • Compared to an average industry Dividend Yield of 0.42, CXT pays a better dividend. On top of this CXT pays more dividend than 93.55% of the companies listed in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.82, CXT has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 1.59%

5.2 History

  • The dividend of CXT is nicely growing with an annual growth rate of 6.42%!
  • CXT has been paying a dividend for at least 10 years, so it has a reliable track record.
  • CXT has decreased its dividend recently.
Dividend Growth(5Y)6.42%
Div Incr Years1
Div Non Decr Years1
CXT Yearly Dividends per shareCXT Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5

5.3 Sustainability

  • 26.88% of the earnings are spent on dividend by CXT. This is a low number and sustainable payout ratio.
  • CXT's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP26.88%
EPS Next 2Y8.36%
EPS Next 3Y6.31%
CXT Yearly Income VS Free CF VS DividendCXT Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M
CXT Dividend Payout.CXT Dividend Payout, showing the Payout Ratio.CXT Dividend Payout.PayoutRetained Earnings

CXT Fundamentals: All Metrics, Ratios and Statistics

CRANE NXT CO

NYSE:CXT (4/30/2026, 2:02:04 PM)

44.36

+0.74 (+1.7%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Industry Strength62.11
Industry Growth70.19
Earnings (Last)02-11
Earnings (Next)05-06
Inst Owners113.84%
Inst Owner ChangeN/A
Ins Owners0.28%
Ins Owner Change5.96%
Market Cap2.55B
Revenue(TTM)1.66B
Net Income(TTM)145.10M
Analysts81.82
Price Target89.18 (101.04%)
Short Float %12.59%
Short Ratio8.13
Dividend
Industry RankSector Rank
Dividend Yield 1.59%
Yearly Dividend0.68
Dividend Growth(5Y)6.42%
DP26.88%
Div Incr Years1
Div Non Decr Years1
Ex-Date02-27
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)0.06%
Min EPS beat(2)0.03%
Max EPS beat(2)0.1%
EPS beat(4)4
Avg EPS beat(4)1.37%
Min EPS beat(4)0.03%
Max EPS beat(4)3.95%
EPS beat(8)6
Avg EPS beat(8)0.66%
EPS beat(12)10
Avg EPS beat(12)5.62%
EPS beat(16)13
Avg EPS beat(16)5.54%
Revenue beat(2)2
Avg Revenue beat(2)3.34%
Min Revenue beat(2)1.89%
Max Revenue beat(2)4.78%
Revenue beat(4)3
Avg Revenue beat(4)1.73%
Min Revenue beat(4)-2.45%
Max Revenue beat(4)4.78%
Revenue beat(8)4
Avg Revenue beat(8)0.72%
Revenue beat(12)7
Avg Revenue beat(12)1.19%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-2.39%
PT rev (3m)-5.41%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-34.82%
EPS NY rev (1m)-0.04%
EPS NY rev (3m)-5.08%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-2.95%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.28%
Valuation
Industry RankSector Rank
PE 10.93
Fwd PE 10.28
P/S 1.54
P/FCF 12.87
P/OCF 10.57
P/B 2.04
P/tB N/A
EV/EBITDA 8.86
EPS(TTM)4.06
EY9.15%
EPS(NY)4.31
Fwd EY9.73%
FCF(TTM)3.45
FCFY7.77%
OCF(TTM)4.2
OCFY9.46%
SpS28.79
BVpS21.78
TBVpS-8.14
PEG (NY)1.74
PEG (5Y)9.75
Graham Number44.601 (0.54%)
Profitability
Industry RankSector Rank
ROA 4.66%
ROE 11.58%
ROCE 10.34%
ROIC 7.93%
ROICexc 8.69%
ROICexgc 29.25%
OM 15.91%
PM (TTM) 8.76%
GM 42.48%
FCFM 11.97%
ROA(3y)7.07%
ROA(5y)6.96%
ROE(3y)16.13%
ROE(5y)16.85%
ROIC(3y)11.93%
ROIC(5y)11.12%
ROICexc(3y)13.26%
ROICexc(5y)12.51%
ROICexgc(3y)48.49%
ROICexgc(5y)45.78%
ROCE(3y)15.59%
ROCE(5y)14.95%
ROICexgc growth 3Y-18.71%
ROICexgc growth 5Y16.5%
ROICexc growth 3Y-13.43%
ROICexc growth 5Y8.62%
OM growth 3Y-6.41%
OM growth 5Y12.78%
PM growth 3Y-16.95%
PM growth 5Y5.97%
GM growth 3Y-3.13%
GM growth 5Y3.98%
F-Score4
Asset Turnover0.53
Health
Industry RankSector Rank
Debt/Equity 0.91
Debt/FCF 5.75
Debt/EBITDA 3.08
Cap/Depr 40.53%
Cap/Sales 2.61%
Interest Coverage 4.74
Cash Conversion 65.25%
Profit Quality 136.66%
Current Ratio 1.5
Quick Ratio 1.2
Altman-Z 1.9
F-Score4
WACC9.88%
ROIC/WACC0.8
Cap/Depr(3y)44.3%
Cap/Depr(5y)36.54%
Cap/Sales(3y)2.63%
Cap/Sales(5y)2.17%
Profit Quality(3y)119.51%
Profit Quality(5y)128.53%
High Growth Momentum
Growth
EPS 1Y (TTM)-4.92%
EPS 3Y-19.21%
EPS 5Y1.12%
EPS Q2Q%5.83%
EPS Next Y6.26%
EPS Next 2Y8.36%
EPS Next 3Y6.31%
EPS Next 5YN/A
Revenue 1Y (TTM)11.43%
Revenue growth 3Y7.33%
Revenue growth 5Y-9.71%
Sales Q2Q%19.49%
Revenue Next Year6.38%
Revenue Next 2Y5.29%
Revenue Next 3Y4.31%
Revenue Next 5YN/A
EBIT growth 1Y-14.09%
EBIT growth 3Y0.45%
EBIT growth 5Y1.82%
EBIT Next Year18.82%
EBIT Next 3Y9.51%
EBIT Next 5YN/A
FCF growth 1Y17.55%
FCF growth 3Y-11.36%
FCF growth 5Y-6.44%
OCF growth 1Y12.8%
OCF growth 3Y-7.59%
OCF growth 5Y-4.84%

CRANE NXT CO / CXT Fundamental Analysis FAQ

What is the fundamental rating for CXT stock?

ChartMill assigns a fundamental rating of 6 / 10 to CXT.


Can you provide the valuation status for CRANE NXT CO?

ChartMill assigns a valuation rating of 8 / 10 to CRANE NXT CO (CXT). This can be considered as Undervalued.


How profitable is CRANE NXT CO (CXT) stock?

CRANE NXT CO (CXT) has a profitability rating of 8 / 10.


What is the financial health of CRANE NXT CO (CXT) stock?

The financial health rating of CRANE NXT CO (CXT) is 3 / 10.


What is the earnings growth outlook for CRANE NXT CO?

The Earnings per Share (EPS) of CRANE NXT CO (CXT) is expected to grow by 6.26% in the next year.